{"Title": "Clinical benefit of drugs targeting mitochondrial function as an adjunct to reperfusion in ST-segment elevation myocardial infarction: A meta-analysis of randomized clinical trials", "Year": 2017, "Source": "Int. J. Cardiol.", "Volume": "244", "Issue": null, "Art.No": null, "PageStart": 59, "PageEnd": 66, "CitedBy": 11, "DOI": "10.1016/j.ijcard.2017.06.040", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85020781298&origin=inward", "Abstract": "\u00a9 2017 Elsevier B.V.Aims To perform a systematic review and meta-analysis of randomized clinical trials (RCT) comparing the effectiveness of drugs targeting mitochondrial function vs. placebo in patients with ST-segment elevation myocardial infarction (STEMI) undergoing mechanical coronary reperfusion. Methods Inclusion criteria: RCTs enrolling STEMI patients treated with primary percutaneous coronary intervention (PCI) and comparing drugs targeting mitochondrial function vs. placebo. Odds ratios (OR) were computed from individual studies and pooled with random-effect meta-analysis. Results Fifteen studies were identified involving 5680 patients. When compared with placebo, drugs targeting mitochondrial component/pathway were not associated with significant reduction of cardiovascular and all-cause mortality (OR 0.9, 95% CI 0.7\u20131.17 and OR 0.92, 95% CI 0.69\u20131.23, respectively). However, these agents significantly reduced hospital admission for heart failure (HF) (OR 0.64; 95% CI 0.45\u20130.92) and increased left ventricular ejection fraction (LVEF) (OR 1.44; 95% CI 1.15\u20131.82). After analysis for subgroups according to the mechanism of action, drugs with direct/selective action did not reduce any outcome. Conversely, those with indirect/unspecific action showed a significant effect on cardiovascular mortality (0.65, 95% CI 0.46\u20130.92), all-cause mortality (OR 0.69, 95% CI 0.52\u20130.92), hospital readmission for HF (OR 0.41, 95% CI 0.28\u20130.6) and LVEF (OR 1.49, 95% CI 1.09\u20132.05). Conclusions Administration of drugs targeting mitochondrial function in STEMI patients undergoing primary PCI appear to have no effect on mortality, but may reduce hospital readmission for HF. The drugs with a broad-spectrum mechanism of action seem to be more effective in reducing adverse events.", "AuthorKeywords": ["Mitochondrial function", "Mortality", "Primary percutaneous coronary intervention", "Reperfusion injury", "ST-segment elevation myocardial infarction"], "IndexKeywords": ["Cardiovascular Agents", "Drug Delivery Systems", "Humans", "Mitochondria", "Myocardial Reperfusion", "Randomized Controlled Trials as Topic", "ST Elevation Myocardial Infarction", "Treatment Outcome"], "DocumentType": "Journal", "PublicationStage": null, "OpenAccess": 2, "EID": "2-s2.0-85020781298", "SubjectAreas": [["Cardiology and Cardiovascular Medicine", "MEDI", "2705"]], "AuthorData": {"8937083300": {"Name": "Campo G.", "AuthorID": "8937083300", "AffiliationID": "114535686", "AffiliationName": "Cardiology Unit, Azienda Ospedaliero-Universitaria di Ferrara"}, "55245988000": {"Name": "Pavasini R.", "AuthorID": "55245988000", "AffiliationID": "114535686", "AffiliationName": "Cardiology Unit, Azienda Ospedaliero-Universitaria di Ferrara"}, "55572240700": {"Name": "Biscaglia S.", "AuthorID": "55572240700", "AffiliationID": "114535686", "AffiliationName": "Cardiology Unit, Azienda Ospedaliero-Universitaria di Ferrara"}, "36047514600": {"Name": "Ferrari R.", "AuthorID": "36047514600", "AffiliationID": "60086672, 60117076", "AffiliationName": "Maria Cecilia Hospital, GVM Care & Research, E.S.: Health Science Foundation"}, "57194437455": {"Name": "Morciano G.", "AuthorID": "57194437455", "AffiliationID": "60024690", "AffiliationName": "Department of Morphology, Surgery and Experimental Medicine, Section of Pathology, Oncology and Experimental Biology, University of Ferrara"}, "7003366639": {"Name": "Pinton P.", "AuthorID": "7003366639", "AffiliationID": "60024690", "AffiliationName": "Department of Morphology, Surgery and Experimental Medicine, Section of Pathology, Oncology and Experimental Biology, University of Ferrara"}, "7005407672": {"Name": "Lincoff A.M.", "AuthorID": "7005407672", "AffiliationID": "60021160", "AffiliationName": "Cleveland Clinic Coordinating Center for Clinical Research (C5Research)"}, "13407121600": {"Name": "Gibson C.M.", "AuthorID": "13407121600", "AffiliationID": "60002746, 60030058", "AffiliationName": "PERFUSE Study Group, Cardiovascular Division, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School"}, "57194558499": {"Name": "Neil B.J.", "AuthorID": "57194558499", "AffiliationID": "60002746, 60030058", "AffiliationName": "PERFUSE Study Group, Cardiovascular Division, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School"}, "7101833765": {"Name": "Kitakaze M.", "AuthorID": "7101833765", "AffiliationID": "60016372", "AffiliationName": "Cardiovascular Division of Medicine, National Cardiovascular Centre"}, "7006487817": {"Name": "Asakura M.", "AuthorID": "7006487817", "AffiliationID": "60016372", "AffiliationName": "Cardiovascular Division of Medicine, National Cardiovascular Centre"}, "12240126300": {"Name": "Lonborg J.", "AuthorID": "12240126300", "AffiliationID": "60006564", "AffiliationName": "Department of Cardiology, Rigshospitalet"}, "7004069840": {"Name": "Engstrom T.", "AuthorID": "7004069840", "AffiliationID": "60006564", "AffiliationName": "Department of Cardiology, Rigshospitalet"}, "56637130000": {"Name": "Ahluwalia A.", "AuthorID": "56637130000", "AffiliationID": "60021435, 60022109", "AffiliationName": "Centre of Clinical Pharmacology, Barts NIHR Cardiovascular Biomedical Research Unit, William Harvey Research Institute, Barts & The London Medical School, Queen Mary University"}, "55568508950": {"Name": "Jones D.A.", "AuthorID": "55568508950", "AffiliationID": "60021435, 60022109", "AffiliationName": "Centre of Clinical Pharmacology, Barts NIHR Cardiovascular Biomedical Research Unit, William Harvey Research Institute, Barts & The London Medical School, Queen Mary University"}, "35247982000": {"Name": "Ishii H.", "AuthorID": "35247982000", "AffiliationID": "60161458", "AffiliationName": "Department of Cardiology, Nagoya University Graduate School of Medicine"}, "7004392953": {"Name": "Frenneaux M.", "AuthorID": "7004392953", "AffiliationID": "60117932, 60000112", "AffiliationName": "Norwich Medical School, University of East Anglia"}, "7006444103": {"Name": "Ovize M.", "AuthorID": "7006444103", "AffiliationID": "101761725", "AffiliationName": "Clinical Investigation Center of Lyon"}, "56208253200": {"Name": "Galvani M.", "AuthorID": "56208253200", "AffiliationID": "60070527", "AffiliationName": "Unit\u00e0 Operativa di Cardiologia, Ospedale GB Morgagni"}, "55935953100": {"Name": "Ottani F.", "AuthorID": "55935953100", "AffiliationID": "60070527", "AffiliationName": "Unit\u00e0 Operativa di Cardiologia, Ospedale GB Morgagni"}, "7005111567": {"Name": "Atar D.", "AuthorID": "7005111567", "AffiliationID": "60105037, 60010348", "AffiliationName": "Department of Cardiology B, Oslo University Hospital Ullevall, Faculty of Medicine, University of Oslo"}, "13907649300": {"Name": "Ibanez B.", "AuthorID": "13907649300", "AffiliationID": "60011100, 60019290", "AffiliationName": "Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) and Instituto de Investigaci\u00f3n-Fundaci\u00f3n Jim\u00e9nez D\u00edaz Hospital"}, "6604027730": {"Name": "Cerisano G.", "AuthorID": "6604027730", "AffiliationID": "60021859, 60021921", "AffiliationName": "Division of Cardiology, University of Florence, Careggi Hospital"}, "7402379761": {"Name": "Dawson D.", "AuthorID": "7402379761", "AffiliationID": "60015875", "AffiliationName": "School of Medicine and Dentistry, University of Aberdeen"}}}